Frontage Laboratories at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Frontage Laboratories brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans, and exhibits at Booth 1400. Its program spans bioanalysis and the oral delivery of biologics. Its work covers a circulating tumour DNA methylation platform for detecting minimal residual disease, and an early proof-of-concept trial of enteric-coated capsules carrying an anti-CD3 antibody taken by mouth.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Frontage Laboratories Exton, PA | |
Contract research organization providing bioanalytical, DMPK, safety, CMC and early clinical services to drug developers. | Booth Exhibiting at Booth 1400 Mon, Oct 268:30am–5:00pmTue, Oct 278:30am–5:00pmWed, Oct 288:30am–1:30pm Poster Mon Oct 26 9:30am–10:30am A Multimodal-Ready ctDNA Methylation Platform for Sensitive Minimal Residual Disease Detection Poster Mon Oct 26 1:30pm–2:30pm Enteric Coated Capsules for Oral Delivery of Anti-CD3 Monoclonal Antibody (mAb): An Early Phase Proof-of-Concept Trial |
Instantly find 20 buyers from Frontage Laboratories
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction